Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q4 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.